Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
18.52
-0.24 (-1.28%)
May 11, 2026, 4:00 PM EDT - Market closed
Crescent Biopharma Employees
Crescent Biopharma had 44 employees as of December 31, 2025. The number of employees increased by 38 or 633.33% compared to the previous year.
Employees
44
Change
38
Growth
633.33%
Revenue / Employee
$270,068
Profits / Employee
-$3,683,568
Market Cap
615.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 44 | - | - |
| Sep 30, 2025 | 41 | - | - |
| Jun 30, 2025 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Gyre Therapeutics | 625 |
| Arvinas | 246 |
| CorMedix | 191 |
| Cabaletta Bio | 156 |
| Prime Medicine | 146 |
| Kyverna Therapeutics | 130 |
| BridgeBio Oncology Therapeutics | 92 |
CBIO News
- 5 days ago - Crescent Biopharma to Present at May Investor Conferences - GlobeNewsWire
- 12 days ago - Crescent Biopharma reports Q1 EPS (70c), consensus (79c) - TheFly
- 12 days ago - Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 17 days ago - Crescent Biopharma Announces Grants of Inducement Awards - GlobeNewsWire
- 4 weeks ago - Crescent Biopharma management to meet with Cantor Fitzgerald - TheFly
- 2 months ago - Crescent Biopharma Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Crescent Biopharma Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Crescent Biopharma price target lowered to $22 from $25 at H.C. Wainwright - TheFly